http://www.asm.org/modules/mod_image_show_gk4/cache/Science Advisor Slidegk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/World AIDS Day Bannergk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Amy Chang Bannergk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/2016.Kavli Slide Submitgk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Governance Hero Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
04-12-2016Science Advisor
04-12-2016World AIDS Day
04-12-2016Amy Chang
04-12-2016Kavli Submit
04-12-2016Nominate
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Antibacterial Development Conference
REGISTER
The ASM filed an Amicus Curiae brief in August, which provided information about scientific matters related to the need and safety of Biosafety Level 4 laboratories. The Massachusetts Supreme Court will hear arguments on September 5 in the case involving public opposition to the construction of a federally funded BSL 4 facility, the National Emerging Infectious Diseases Laboratories (NEIDL), at the Boston University Medical Campus. The ASM brief described the tremendous impact on society of infectious diseases and the emergence of new and resistant infectious diseases globally, in the last 30 years, providing information to the Court about the need for high containment laboratories to study pathogens and to develop new vaccines, diagnostics and therapeutics. The brief described the requirements for strict adherence of high containment laboratories to relevant safety and security standards, practices and procedures, required by government policies.
 

TPL_asm2013_SEARCH

2150